Complementary, alternative medicine integration into clinical cancer care needs to be individualized
the ONA take:
Researchers at the Abramson Cancer Center at the University of Pennsylvania’s Perelman School of Medicine conducted a survey-based study to determine what drives the use of complementary and alternative medicine (CAM) among cancer patients.
The researchers surveyed 969 patients from the institution’s thoracic, breast, and gastrointestinal medical oncology clinics.
The findings reveal that expectation of therapeutic benefits, patient-perceived barriers regarding cost and access, and opinions of patients’ physician and family members predict patients’ use of CAM.
These beliefs and attitudes varied by key socio-demographic factors such as sex, race, and education.
Proven effectiveness of CAM practices such as yoga and acupuncture continue to support the practice of integrative oncology, which merges complementary and alternative medicine with conventional medicine to improve patient outsomes.
The researchers conclude that patient education on CAM practices should be tailored to the individual patient when integrating them into clinical care.
A study to determine what drives the use of complementary and alternative medicine among cancer patients.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|